U.S. Federal Register Tool

Airworthiness Directives; The Boeing Company Airplanes

The FAA is adopting a new airworthiness directive (AD) for certain The Boeing Company Model 787-8, 787-9, and 787-10 airplanes. This AD was prompted by a Boeing investigation for manufacturing errors and excessive preload forces at the lower side of body (SOB) splice plates common to the lower outboard wing skins. That investigation concluded that shim gaps may have exceeded engineering allowances, and high pull up forces on the components may cause fatigue cracks to form at the fastener holes. This AD requires, depending on configuration, repetitive ultrasonic (UT) inspections at certain splice plates, rear spar terminal fittings, lower chords, front spar terminal fittings, and jack pads for any cracks; repetitive detailed inspections (DET) of certain splice plates for any cracks; and applicable on-condition actions. The FAA is issuing this AD to address the unsafe condition on these products.

Airworthiness Directives; Airbus SAS Airplanes

The FAA is adopting a new airworthiness directive (AD) for certain Airbus SAS Model A320-211, -212, -214, -216, -231, -232, and - 233 airplanes; and Model A321-111, -112, -131, -211, -212, -213, -231, and -232 airplanes. This AD was prompted by a fatigue test that identified cracks in the forward and aft upper corner of the bulk cargo door. This AD requires a rototest inspection for cracks and applicable on-condition actions. The FAA is issuing this AD to address the unsafe condition on these products.

Airworthiness Directives; Airbus SAS Airplanes

The FAA is superseding Airworthiness Directive (AD) 2024-25- 06, which applied to all Airbus SAS Model A318 and A320 series airplanes; and Model A319-111, -112, -113, -114, -115, -131, -132, - 133, -151N, -153N, and -171N airplanes; and Model A321-111, -112, -131, -211, -212, -213, -231, -232, -251N, -252N, -253N, -271N, -272N, - 251NX, -252NX, -253NX, -271NX, -272NX, and -253NY airplanes. AD 2024- 25-06 required repetitive inspections of the main landing gear (MLG) door actuators and, depending on findings, accomplishment of applicable corrective actions, and prohibited the installation of affected parts. Since the FAA issued AD 2024-05-06, the FAA determined that replacing the MLG door actuators is necessary to address the unsafe condition, and the applicability and definition of an affected part must be expanded. This AD continues to require the actions in AD 2024-25-06, requires replacing affected parts with serviceable parts, and expands the applicability and definition of an affected part. The FAA is issuing this AD to address the unsafe condition on these products.

Agency Information Collection Activity Under OMB Review: CFM Stakeholder Feedback Survey

In compliance with the Paperwork Reduction Act (PRA) of 1995, this notice announces that the Office of Construction and Facilities Management, Department of Veterans Affairs, will submit the collection of information abstracted below to the Office of Management and Budget (OMB) for review and comment. The PRA submission describes the nature of the information collection and its expected cost and burden, and it includes the actual data collection instrument.

Renewal of the Commission on Social Impact Partnerships

The Treasury Department will renew the charter for the Commission on Social Impact Partnerships for a two-year period beginning no sooner than seven days following publication of this notice.

Farmer Bridge Assistance (FBA) Program; Correction

The Commodity Credit Corporation (CCC) announced the Farmer Bridge Assistance (FBA) Program in a final rule on February 23, 2026. This correction amends the definition of "corn" to add blue and red corn, which are eligible commodities for the FBA Program.

Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV

On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place cipepofol, chemically known as 2-[(1R)-1-cyclopropylethyl]-6- isopropylphenol, in schedule IV of the Controlled Substances Act (CSA). In accordance with the CSA, as amended by the Improving Regulatory Transparency for New Medical Therapies Act, DEA is hereby issuing an interim final rule placing cipepofol in schedule IV of the CSA.

Center for Scientific Review; Notice of Closed Meetings

Report Under Public Law 119-38

The Department of Justice is publishing a report submitted to Congress concerning records released and withheld pursuant to Public Law 119-38.

Agency Information Collection Activity Under OMB Review: Freedom of Information Act (FOIA) or Privacy Act (PA) Request

In compliance with the Paperwork Reduction Act (PRA) of 1995, this notice announces that the Veterans Benefits Administration (VBA), Department of Veterans Affairs, will submit the collection of information abstracted below to the Office of Management and Budget (OMB) for review and comment. The PRA submission describes the nature of the information collection and its expected cost and burden, and it includes the actual data collection instrument.